发明名称 |
Polymorphic forms of icotinib and uses thereof |
摘要 |
The present invention relates to the polymorphic forms of the compound of Formula I, preparation thereof and pharmaceutical compositions, and use of a polymorph above in the treatment of a disease, a disorder or a condition, or in the manufacturing of a medicament for the treatment of a disease, a disorder or a condition.; |
申请公布号 |
US9611272(B2) |
申请公布日期 |
2017.04.04 |
申请号 |
US201414896992 |
申请日期 |
2014.06.09 |
申请人 |
BETTA PHARMACEUTICALS CO., LTD. |
发明人 |
Hu Shaojing;Long Wei;Wang Fei;Wang Yinxiang;Ding Lieming |
分类号 |
A61K31/519;A61K45/06;C07D491/056;A61K9/20;A61K9/48 |
主分类号 |
A61K31/519 |
代理机构 |
Andrews Kurth Kenyon LLP |
代理人 |
Andrews Kurth Kenyon LLP ;Bradin David |
主权项 |
1. A polymorph form of the compound of Formula I, wherein the polymorph form is of Form II and its X-ray powder diffraction pattern has characteristic peaks at diffraction angles 2θ of 5.5°, 11.0°, 19.7°, 20.9° and 22.6°±0.2°. |
地址 |
Hangzhou, Zhejiang CN |